Anesthesia drug may shield ovarian cancer patients from Post-Surgery depression
NCT ID NCT06624878
First seen Feb 28, 2026 · Last updated May 16, 2026 · Updated 12 times
Summary
This study tested whether giving a low dose of esketamine during ovarian cancer surgery could prevent depressive symptoms afterward. Over 500 women undergoing cytoreductive surgery received either esketamine or a placebo. The goal was to see if the drug reduced depression and sleep problems three days after surgery.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for OVARIAN CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Zhejiang cancer hospital
Hangzhou, Zhejiang, 310022, China
Conditions
Explore the condition pages connected to this study.